STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Sera Prognostics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Sera Prognostics insider sale notice (Form 144). The filing reports a proposed sale of 21,158 Class A common shares through Morgan Stanley Smith Barney on 09/09/2025 on NASDAQ, with an aggregate market value listed as $66,572 and total shares outstanding of 38,061,868. The shares were acquired by restricted stock unit vesting and recorded as acquired and to be paid on 09/09/2025. The filer also disclosed sales during the past three months totaling 35,957 shares on 06/09/2025, 06/10/2025, and 08/08/2025 with gross proceeds shown for each sale. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • Regulatory compliance: The filer provided required Rule 144 details including broker, share counts, acquisition method, and recent sales.
  • Clarity on acquisition: Securities to be sold were acquired via restricted stock unit vesting, clearly stated with dates.

Negative

  • None.

Insights

TL;DR: Small insider sale disclosed; amount is immaterial relative to outstanding shares, so market impact appears limited.

The filing documents a proposed sale of 21,158 Class A shares and prior recent sales totaling 35,957 shares. Versus 38.06 million shares outstanding, these transactions represent a very small fraction of the float (~0.09% combined). The shares to be sold were acquired via restricted stock unit vesting, indicating compensation-related origin rather than open-market purchase. From a financial-materiality perspective, these disclosures fulfill regulatory requirements but are unlikely to materially affect company valuation or liquidity.

TL;DR: Filing meets Rule 144 disclosure norms; provides necessary timeline and broker information for compliance.

The Form 144 supplies required details: broker name and address, share counts, acquisition date and nature (restricted stock unit vesting), and recent sale history. The filer attests to lack of undisclosed material adverse information, and the notice includes the standard criminal-misstatement warning. For governance and compliance review, the document appears complete for a Rule 144 sale notice; there is no indication within the filing of any governance or disclosure breach.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SERA Form 144 report?

The filing reports a proposed sale of 21,158 Class A common shares on 09/09/2025 through Morgan Stanley Smith Barney with an aggregate market value of $66,572.

How many SERA shares were outstanding per the filing?

The filing lists 38,061,868 shares outstanding.

What was the acquisition method for the shares to be sold?

The shares were acquired via Restricted Stock Unit Vesting on 09/09/2025.

Were there other SERA insider sales recently disclosed?

Yes. The filer disclosed sales of 23,042 shares on 06/09/2025, 3,344 shares on 06/10/2025, and 8,571 shares on 08/08/2025.

On which exchange will the SERA shares be sold?

The proposed sale is listed for NASDAQ.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

130.45M
33.40M
10.8%
64.96%
1.88%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY